JPH043932B2 - - Google Patents

Info

Publication number
JPH043932B2
JPH043932B2 JP59024409A JP2440984A JPH043932B2 JP H043932 B2 JPH043932 B2 JP H043932B2 JP 59024409 A JP59024409 A JP 59024409A JP 2440984 A JP2440984 A JP 2440984A JP H043932 B2 JPH043932 B2 JP H043932B2
Authority
JP
Japan
Prior art keywords
bacillus licheniformis
milk
milk substitute
bacteria
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59024409A
Other languages
Japanese (ja)
Other versions
JPS60168339A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP59024409A priority Critical patent/JPS60168339A/en
Publication of JPS60168339A publication Critical patent/JPS60168339A/en
Publication of JPH043932B2 publication Critical patent/JPH043932B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は動物用代用乳に関する。更に詳しく
は、バチルス・リケニホルミス菌を有効菌として
含有することを特徴とする動物用代用乳に関する
ものである。 現在、子牛の様な幼若哺乳動物の飼育において
は、母体の保護、母乳の節約、子牛の順調な発育
の達成のため、生後1週令程度から4〜6週令程
度までの間、代用乳とよばれる脱脂粉乳、油脂、
糖類、穀物粉、魚粉等を主成分とする母乳代用乳
品を給与して飼育した後、離乳する飼養方法が最
も一般的に採用されている。従来、この様な動物
用代用乳中には、疾病防止、成長促進等を目的と
して、抗生物質、酵素類、生菌剤等が添加されて
いる。 しかしながらこのうち抗生物質については、副
作用の発現や、その残留移行により、人間にアレ
ルギーや腸内細菌の変化を引き起こす恐れがある
ため、使用上の規制が強められ、使用範囲が限
定、縮少される方向にある。酵素類としてリパー
ゼ剤、アミラーゼ剤、セルラーゼ剤、プロテアー
ゼ剤及びこれらの混合酵素剤などが検討されてい
るが、その効果がまちまちであり常に一定した効
果は期待できないのが現状である。 また生菌剤として納豆菌、乳酸菌、酪酸菌、ビ
フイズス菌等が検討されており、ある程度の効果
は見られるもののまだ十分なものではない。 以上のように、動物用代用乳としては、いまだ
満足すべきものがないのが実情である。 本発明者等は以上の様な情勢下、自然界より分
離したバチルス属菌を動物用代用乳中に含有さ
せ、有効なものを種々検討した結果、意外にもバ
チルス・リケニホルミス菌を有効菌として含有す
る動物用代用乳が、生体毒性もなく、かつ下痢症
等の疾病防止、成長促進効果等の優れた効果を有
する事を見い出し本発明を完成させるに至つた。 本発明は、バチルス・リケニホルミス菌を有効
菌として含有することを特徴とする動物用代用乳
である。 次に本発明を詳細に説明する。 本発明の動物用代用乳が対象とする動物は、乳
用種雌子牛、乳用種雄子牛、(主として肉用に供
す為飼育)、肉用種子牛等が代表的な例であるが、
子豚、子羊、子山羊、子犬、子猫等にも使用する
事ができる。 本発明に用いるバチルス・リケニホルミス菌は
バチルス属に属する通性嫌気性細菌であり、自然
より単離した菌ばかりでなく、その変異菌株も有
効に用いうる。なかでも好ましい菌株としては微
工研条寄第266号にMN−001として寄託された変
異株バチルス・リケニホルミスMN−001株であ
る。 このバチルス・リケニホルミスMN−001株
(以下MN−001株と表わす。)の菌学的性質を示
す。 A 形態 (1) 幅0.5〜0.8μm長さ2〜3μmの桿菌。 (2) グラム染色:陽性。 (3) 楕円状の内生胞子を形成。 (4) 運動性:有。 B 生育 (1) 普通寒天培地:非常に良く生育する。色素
の生成なし。 (2) 糖蜜、硫酸アンモニウムを主体とした培
地:非常に良く生育する。色素の生成なし。 (3) 食塩液体培地 5%:生育する。 7%:生育する。 10%:生育する。 C 生理学的性質 (1) カタラーゼ生成 + (2) 嫌気的条件下での生育 + (3) VP反応 + (4) 高温での生育状態 50℃ + 55℃ − (5) 糖類から酸生成の有無 グルコース + L−アラビノース + D−キシロース + マンニツト + D−タガトース + (6) アルギニン ジヒドロラーゼ+ (7) レシチナーゼ − (8) デンプンの加水分解性 + (9) ゼラチンの加水分解性 + (10) DNAの加水分解性 + (11) クエン酸塩の利用性 + (12) プロピオン酸塩の利用性 + (13) 硝酸還元性 + (14) インドール生成 − (15) フエニルアラニンの脱アミノ化− 本発明の有効菌であるバチルス・リケニホルミ
ス菌を培養するには、通常の醗酵法に準じて、液
体培養、又は固体培養する事によつて行なえばよ
い。 培地としては天然培地、半合成培地、合成培地
等いずれも使用する事ができる。培地の組成は、
(i)炭素源としては、グルコース、サツカロース、
デキストリン、グリセリン、デンプン、糖蜜等
を、(ii)窒素源としては、ペプトン、肉エキス、酵
母エキス、乾燥酵母、大豆粕、尿素、チオ尿素、
アンモニウム塩、硝酸塩、その他有機あるいは無
機窒素化合物を、(iii)無機塩としては、マグネシウ
ム、マンガン、カリウム、カルシウム、鉄等の燐
酸塩、硝酸塩、炭酸塩、塩化物などが用いられ
る。またアミノ酸類、ビタミン類、核酸およびそ
の関連化合物を添加してもよい。培養温度は、通
常の醗酵法に準ずるが、たとえば20℃〜50℃で好
適に培養できる。培養期間も通常の醗酵法に準ず
るがたとえば12時間〜5日で好適に培養できる。 ここに得られた培養物は、そのままもしくは洗
滌をくりかえして菌体のみにして使用することが
できる。また、培養物、その処理物、菌体を、そ
のままもしくは添加料を添加し、凍結乾燥、噴霧
乾燥するなどにより製剤化した後用いる事ができ
る。 更には、たとえば、培養液をそのまま、小麦
粉、デンプン、デキストリン等や、飼料用原料の
穀類、脱脂米ぬか等の糟糖類、油粕等の適当な希
釈剤を用い、製剤化する事も可能である。 又培養液から菌体のみを洗滌分離し、同様に製
剤化して、用いてもよい。 本発明の動物用代用乳は、バチルス・リケニホ
ルミス菌を含有する事を特徴としており、動物用
代用乳を製造する方法には限定されないが、通
常、バチルス・リケニホルミス菌製剤または菌体
のみまたは培養物をそのまま市販の代用乳中に混
合する事により容易に製造される。また代用乳を
製造する際、すなわち脱脂粉乳、ホエー等の乳製
品加工副産物、全脂粉乳、イエローグリスタロ
ー、エキストラフアンシータロー、大豆油、パー
ム油、ココナツツ油等の油脂類、乳糖、ブドウ
糖、果糖、シヨ糖等の糖類、小麦粉、トウモロコ
シ等の穀物粉、魚粉、プロピレングリコール、グ
リセリン等の多価アルコール類、ビタミン、ミネ
ラル、アミノ酸、着香料、化学的保存剤、乳化剤
等の添加剤類の他、当該産業分野で広く使用され
ている諸原料を任意の割合で配合する際に、バチ
ルス・リケニホルミス菌製剤または菌体のみまた
は培養物を、混合する事も可能である。 本発明の動物用代用乳に含有されるバチルス・
リケニホルミス菌は、菌体が代用乳1Kg当り102
〜1015個、望ましくは104〜1012個、最も望ましく
は、105〜1010個になるごとく添加するとよい。 本発明の動物用代用乳は、含有されるバチル
ス・リケニホルミス菌の作用により、対象動物に
対し、下痢防止、抑制効果、増体効果、飼料効率
改善効果等の優れた効果を発揮すると共に、極め
て安全性が高いため、産業上の利用価値が高い。 以下、バチルス・リケニホルミス製剤製造例お
よび実施例にて、本発明を更に詳細に説明する。 製造例 〔バチルス・リケニホルミス菌生菌製剤の作
製〕 水道水100重量部に糖蜜2重量部、硫酸アンモ
ニウム1重量部、2塩基性リン酸カリ0.1重量部、
酵母エキス0.05重量部を溶解し、0.1N塩酸及び
0.1NカセイソーダによりPHを8.0に調整した培養
液1をジヤーフアーメンターに入れ、殺菌
(121℃、15分間)後、あらかじめ前培養したバチ
ルス・リケニホルミスMN−001株(微工研条寄
第266号にMN−001として寄託)を接種し、24時
間振とう培養した。次いで遠心分離して培養液か
ら菌体を分離し、この菌体にデンプン1Kgを添加
混合したのち、乾燥させて、バチルス・リケニホ
ルミスMN−001株製剤(以下MN−001製剤と表
わす。)を得た。この製剤中の生菌数は108個/g
であつた。 実施例 1 1週令のホルスタイン種雄子牛10頭を用い、各
群5頭ずつの2群に分け、各群に表1に示した組
成の基本代用乳に、デンプンを添加した対照区用
代用乳およびMN−001製剤(製造例でデンプン
を用いて得た1g当り108個の生菌を含有する製
剤)を添加した試験区用代用乳を作製し、夫々対
照区、試験区とした。飼養試験にあたつては、代
用乳1重量部を温湯7重量部部に溶解、分散させ
た後子牛に給与し、4週間の試験を行なつた。結
果を第2表に示した。 尚、我国の最近の子牛の飼養方法においては、
上記の如き代用乳と共にカーフスターターと呼ば
れるペレツト状飼料(代用乳よりも低蛋白、低脂
肪)を給与する方法が広く採用されているが、本
実施例では、代用乳自体の効果を検討することを
目的とした為、カーフスターターは併用しなかつ
た。
The present invention relates to animal milk substitutes. More specifically, the present invention relates to an animal milk substitute characterized by containing Bacillus licheniformis as an effective bacterium. Currently, when raising young mammals such as calves, in order to protect the mother's body, conserve milk, and achieve smooth growth of the calf, the breeding period is from around 1 week old to around 4 to 6 weeks old. , skim milk powder called milk substitute, fats and oils,
The most commonly adopted feeding method is to feed the cows with a breast milk substitute containing sugars, grain flour, fish meal, etc. as their main ingredients, and then wean them. Conventionally, antibiotics, enzymes, probiotics, and the like have been added to such animal milk substitutes for the purpose of disease prevention, growth promotion, and the like. However, due to the risk of side effects and residual transfer of antibiotics, which may cause allergies and changes in intestinal bacteria in humans, regulations regarding their use have been tightened, and the range of use has been limited and reduced. It is in the direction of As enzymes, lipase agents, amylase agents, cellulase agents, protease agents, and mixtures of these enzyme agents have been studied, but their effects vary and it is currently impossible to expect a constant effect. In addition, Bacillus natto, lactic acid bacteria, butyric acid bacteria, Bifidobacterium, and the like have been studied as viable bacterial agents, and although some effects have been seen, they are still not sufficient. As mentioned above, the reality is that there is still no satisfactory milk substitute for animals. Under the above circumstances, the present inventors included Bacillus bacteria isolated from nature in animal milk substitutes, and as a result of various studies on effective ones, they unexpectedly found that Bacillus licheniformis was included as an effective bacteria. The present inventors have discovered that a milk substitute for animals is not toxic to the body and has excellent effects such as preventing diseases such as diarrhea and promoting growth, leading to the completion of the present invention. The present invention is an animal milk substitute characterized by containing Bacillus licheniformis as an effective bacterium. Next, the present invention will be explained in detail. Typical examples of animals targeted by the animal milk substitute of the present invention include dairy female calves, dairy male calves (raised mainly for meat), and beef seed cows.
It can also be used for piglets, lambs, kids, puppies, kittens, etc. Bacillus licheniformis used in the present invention is a facultative anaerobic bacterium belonging to the genus Bacillus, and not only bacteria isolated from nature but also mutant strains thereof can be effectively used. Among these, a preferred strain is the mutant strain Bacillus licheniformis MN-001, which was deposited as MN-001 in FIKEN Article No. 266. The mycological properties of this Bacillus licheniformis strain MN-001 (hereinafter referred to as MN-001 strain) are shown. A. Morphology (1) Bacillus with a width of 0.5-0.8 μm and a length of 2-3 μm. (2) Gram staining: positive. (3) Forms oval endospores. (4) Motility: Yes. B Growth (1) Ordinary agar medium: Grows very well. No pigment formation. (2) Medium based on molasses and ammonium sulfate: Grows very well. No pigment formation. (3) 5% saline liquid medium: Grows. 7%: Grows. 10%: Grow. C Physiological properties (1) Catalase production + (2) Growth under anaerobic conditions + (3) VP reaction + (4) Growth status at high temperature 50℃ + 55℃ - (5) Presence or absence of acid production from sugars Glucose + L-arabinose + D-xylose + Mannite + D-tagatose + (6) Arginine dihydrolase + (7) Lecithinase - (8) Hydrolyzability of starch + (9) Hydrolyzability of gelatin + (10) DNA Hydrolyzability + (11) Citrate availability + (12) Propionate availability + (13) Nitrate reduction + (14) Indole formation − (15) Deamination of phenylalanine − Book Bacillus licheniformis, which is an effective bacterium of the invention, can be cultured by liquid culture or solid culture according to a conventional fermentation method. As the medium, natural medium, semi-synthetic medium, synthetic medium, etc. can all be used. The composition of the medium is
(i) Carbon sources include glucose, sutucarose,
(ii) Nitrogen sources include peptone, meat extract, yeast extract, dried yeast, soybean meal, urea, thiourea,
Ammonium salts, nitrates, and other organic or inorganic nitrogen compounds; (iii) Inorganic salts include phosphates, nitrates, carbonates, and chlorides of magnesium, manganese, potassium, calcium, iron, and the like. Also, amino acids, vitamins, nucleic acids and related compounds may be added. The culture temperature is similar to that of a normal fermentation method, but the culture can be suitably carried out at, for example, 20°C to 50°C. The culture period is also similar to that of a normal fermentation method, but for example, 12 hours to 5 days is suitable for culturing. The culture thus obtained can be used as it is or by repeated washing to obtain only the bacterial cells. Furthermore, the culture, its treated product, and the bacterial cells can be used as they are or after being formulated into a formulation by adding additives and freeze-drying, spray-drying, or the like. Furthermore, for example, it is also possible to formulate a formulation from the culture solution as it is by using appropriate diluents such as wheat flour, starch, dextrin, etc., grains as raw materials for feed, saccharides such as defatted rice bran, oil cake, etc. Alternatively, only the bacterial cells may be washed and separated from the culture solution, formulated in the same manner, and used. The animal milk substitute of the present invention is characterized by containing Bacillus licheniformis, and although the method for producing the animal milk substitute is not limited, it is usually a Bacillus licheniformis preparation, only bacterial cells, or a culture. It is easily produced by mixing directly into a commercially available milk substitute. In addition, when producing milk substitutes, skim milk powder, dairy processing by-products such as whey, whole milk powder, yellow grease taro, extra fluffy tallow, oils and fats such as soybean oil, palm oil, coconut oil, lactose, glucose, etc. Sugars such as fructose and sucrose, grain flours such as wheat flour and corn, fishmeal, polyhydric alcohols such as propylene glycol and glycerin, additives such as vitamins, minerals, amino acids, flavoring agents, chemical preservatives, and emulsifiers. In addition, when blending various raw materials widely used in the relevant industrial field in arbitrary proportions, it is also possible to mix Bacillus licheniformis bacterial preparations, bacterial cells alone, or cultures. Bacillus contained in the animal milk substitute of the present invention
Licheniformis bacteria has 10 2 bacterial cells per 1 kg of milk substitute.
It is preferable to add 10 15 to 10 15 pieces, preferably 10 4 to 10 12 pieces, most preferably 10 5 to 10 10 pieces. The animal milk substitute of the present invention exhibits excellent effects such as preventing diarrhea, suppressing effects, increasing body weight, and improving feed efficiency on target animals due to the action of Bacillus licheniformis bacteria contained therein. It has high industrial value because of its high safety. The present invention will be explained in more detail below with reference to Bacillus licheniformis preparation production examples and examples. Production example [Preparation of Bacillus licheniformis live bacteria preparation] 100 parts by weight of tap water, 2 parts by weight of molasses, 1 part by weight of ammonium sulfate, 0.1 part by weight of dibasic potassium phosphate,
Dissolve 0.05 parts by weight of yeast extract, add 0.1N hydrochloric acid and
Culture solution 1 whose pH was adjusted to 8.0 with 0.1N caustic soda was placed in a jar fermentor, and after sterilization (121°C, 15 minutes), Bacillus licheniformis MN-001 strain precultured (Feikoken Joyori No. 266) was sterilized (121°C, 15 minutes). No. MN-001) was inoculated and cultured with shaking for 24 hours. Next, the bacterial cells were separated from the culture solution by centrifugation, and 1 kg of starch was added to and mixed with the bacterial cells, followed by drying to obtain a Bacillus licheniformis MN-001 strain preparation (hereinafter referred to as MN-001 preparation). Ta. The number of viable bacteria in this preparation is 108 /g
It was hot. Example 1 Using 10 1-week-old Holstein male calves, they were divided into 2 groups of 5 cows in each group, and each group was given a control group of milk replacer with the composition shown in Table 1 plus starch. Milk substitutes for test plots were prepared by adding milk and MN-001 formulation (preparation containing 10 8 viable bacteria per gram obtained using starch in the production example) and used as a control group and a test group, respectively. In the feeding test, 1 part by weight of milk replacer was dissolved and dispersed in 7 parts by weight of warm water, and then fed to calves, and the test was conducted for 4 weeks. The results are shown in Table 2. In addition, in the recent method of raising calves in Japan,
A method of feeding a pelleted feed called calf starter (lower in protein and fat than the milk replacer) along with the milk replacer as described above is widely adopted, but in this example, the effect of the milk replacer itself was investigated. Because this was the purpose, a calf starter was not used.

【表】【table】

【表】【table】

Claims (1)

【特許請求の範囲】 1 バチルス・リケニホルミス菌を有効菌として
含有することを特徴とする動物用代用乳。 2 バチルス・リケニホルミス菌が微工研条寄第
266号にMN−001として寄託されているバチル
ス・リケニホルミスMN−001株である特許請求
の範囲第1項記載の動物用代用乳。
[Scope of Claims] 1. An animal milk substitute characterized by containing Bacillus licheniformis as an effective bacterium. 2. Bacillus licheniformis bacterium
The animal milk substitute according to claim 1, which is Bacillus licheniformis MN-001 strain deposited as MN-001 in No. 266.
JP59024409A 1984-02-14 1984-02-14 Substitute milk for animal Granted JPS60168339A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP59024409A JPS60168339A (en) 1984-02-14 1984-02-14 Substitute milk for animal

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59024409A JPS60168339A (en) 1984-02-14 1984-02-14 Substitute milk for animal

Publications (2)

Publication Number Publication Date
JPS60168339A JPS60168339A (en) 1985-08-31
JPH043932B2 true JPH043932B2 (en) 1992-01-24

Family

ID=12137364

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59024409A Granted JPS60168339A (en) 1984-02-14 1984-02-14 Substitute milk for animal

Country Status (1)

Country Link
JP (1) JPS60168339A (en)

Also Published As

Publication number Publication date
JPS60168339A (en) 1985-08-31

Similar Documents

Publication Publication Date Title
DK175045B1 (en) Animal and animal probiotics containing BACILLUS SUBTILIS C-3102
JP5872104B2 (en) New Bacillus subtilis {NOVELBACILLUSSUBTILIS}
KR900003014B1 (en) Feed additives for fishing
CN1997387B (en) Methods and compositions for improving growth of meat-type poultry
RU2412612C1 (en) Method for production of "ferm km" probiotic fodder additive for domestic animals and birds
US11110134B2 (en) Direct-fed microbials
JPH05507202A (en) Hemicellulase supplements to improve the energy efficiency of hemicellulose-containing foods and animal feeds
WO1993014187A1 (en) A bacterial strain of the species bacillus coagulans: its use as a probiotic agent
WO2021003793A1 (en) Bacillus haynesii ly-23, bacterial agent, application thereof and product using same
Rexen Use of enzymes for improvement of feed
JPH0434371B2 (en)
US11382940B2 (en) Lactobacillus salivarius CJLS1511, animal feed additive composition comprising same bacterium or dead cells thereof, and method for producing same dead cells
CN113412058A (en) Composition containing bacterium producing bacillaene or preparation thereof
JP2008048683A (en) Viable bacteria agent for animal, feed composition, and method for using the agent and the composition
KR102131882B1 (en) Method for preparing fermented composition with improved odor using yeast
US20120128827A1 (en) FUNCTIONAL FEEDS WITH HIGH SOY FLOUR, STARCH AND Bacillus SPP CONTENT
US3243299A (en) Monogastric feed concentrate containing rumen microorganisms and lactic ferment and process of preparation
KR880001275B1 (en) Manufacturing process for making animal feeds
RU2675934C2 (en) Combined probiotic preparation based on spore-forming bacteria of bacillus genus (options) for use in animal breeding, method for production thereof (variants) and bacillus subtilis (natto) strain used as additive for preparation
LV12340B (en) A method for producing food additive, food additive and the use of it
JPH043932B2 (en)
JP2582092B2 (en) Livestock and poultry feed composition
KR101190790B1 (en) Novel bacillus sp. cjb-01 strain and feed additives
JPS59179037A (en) Feed additive and feed for animal
JPH0379986B2 (en)